fangchinoline has been researched along with transforming growth factor beta in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, KS; Alahmadi, TA; Alharbi, SA; Chinnathambi, A; Jung, YY; Kumar, AP; Sethi, G | 1 |
1 other study(ies) available for fangchinoline and transforming growth factor beta
| Article | Year |
|---|---|
Fangchinoline targets epithelial-mesenchymal transition process by modulating activation of multiple cell-signaling pathways.
Topics: Benzylisoquinolines; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Epithelial-Mesenchymal Transition; Humans; Phosphatidylinositol 3-Kinases; Signal Transduction; Transforming Growth Factor beta | 2022 |